Canada markets closed

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.6500+0.0600 (+1.31%)
At close: 04:00PM EDT
4.5000 -0.15 (-3.23%)
After hours: 06:52PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
54,807
54,807
113,323
90,622
35,973
Selling General and Administrative
48,895
48,895
47,926
35,082
24,866
Total Operating Expenses
103,702
103,702
161,249
125,703
60,839
Operating Income or Loss
-103,702
-103,702
-161,249
-125,703
-60,839
Total Other Income/Expenses Net
-241.157
-241.157
1,546
-1,247
-16.946
Income Before Tax
-98,792
-98,792
-157,044
-125,752
-59,456
Income from Continuing Operations
-98,792
-98,792
-157,044
-125,752
-59,456
Net Income
-98,792
-98,792
-157,044
-125,752
-59,456
Net Income available to common shareholders
-98,792
-98,792
-157,044
-125,752
-59,456
Basic EPS
-1.33
-3.28
-5.30
-7.16
-3.81
Diluted EPS
-1.33
-3.28
-5.30
-7.16
-3.81
Basic Average Shares
9,217
30,099
29,629
17,553
15,594
Diluted Average Shares
9,217
30,099
29,629
17,553
15,594